Candel Therapeutics, Inc. (NASDAQ:CADL) Receives $18.00 Average Target Price from Brokerages

Shares of Candel Therapeutics, Inc. (NASDAQ: CADL - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eight research firms that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy